ASTCT HOME MeetingsASTCT EBMT Relapse Conference

INTERNATIONAL CONFERENCE ON
RELAPSE AFTER TRANSPLANT
AND CELLULAR
THERAPY (HSCT²)

This conference will return 14-15 November in
Madrid, Spain. Registration is now open!

About the Conference

The American Society for Transplantation and Cellular Therapy (ASTCT)/The European Society for Blood and Marrow Transplantation (EBMT) are proud to present the ASTCT+EBMT 7th International Conference on Relapse after Transplant and Cellular Therapy on November 14-15 in Madrid, Spain.

Hematopoietic stem cell transplantation and cellular therapy (HSCT2) are life-saving treatment options for many hematologic malignancies and some solid tumours. Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with both allogeneic and autologous hematopoietic stem cell transplantation (HSCT) and also CAR T cell therapy. Since the first symposium, more than 12 years ago, we have witnessed tremendous progress in our understanding and treatment of relapse including the development of therapies specifically licensed to treat or prevent relapse post HSCT and cellular therapies.

The conference will feature internationally recognized speakers from a multidisciplinary, diverse group comprised of basic and translational scientists and clinical investigators. The conference will include formal didactic presentations and informal discussion panels. It will also offer investigators interested in the field the opportunity to present their work in dedicated oral and poster sessions. As in previous years, abstracts will be selected for oral presentation in the meeting.

The planned objectives of the 7th International Conference are designed to present the latest scientific and clinical advances related to relapse after HSCT and to provide a forum for the presentation of ongoing laboratory, translational, and clinical research specifically related to this field.

The goals of the conference are to review the state of the science and basic, translational and clinical research related to relapse after allogeneic and autologous HSCT, along with cellular therapies.

Update the current state of the science relative to biology and clinical study of relapse related to autologous and allogeneic HSCT, along with cellular therapies.
Provide a forum for the presentation of ongoing laboratory and translational research specifically related to relapse following HSCT or cellular therapy.
Provide a forum to present ongoing clinical trials that are specific to the study of and treatment of relapse following HSCT or cellular therapy.
Provide an overview of the potential role of CAR T cells and other cellular therapies in the prevention and treatment of relapse following HSCT.

Who Should Attend

Medical and pediatric hematologists oncologists
Translational and basic scientists
Hematopathologists, physicians-in-training (Fellows/Residents/Post Docs)
Advance practice providers,
Pharmacists, oncology nurses
Other associated allied health professionals

Registration

Registration for the 2025 meeting is now open!

Category	May 12, 2025 (3:45 p.m. CT)	November 7, 2025 (3:45 p.m. CT)	On-site
	Early	General	Late
Senior Physicians, Scientists and Researchers	400 €	500 €	600 €
Trainee and Junior Faculty*	225 €	200 €	250 €
Allied Health Professionals**	225 €	200 €	200 €
Medical Students \| Virtual Only	150 €	200 €	Not allowed
Industry Representatives***	950 €	950 €	Not allowed

*Junior attendees are defined as post doctoral fellows and junior faculty within the first three years of appointment.

**Nurses, pharmacists, nutritionists, therapists, etc.

***Companies not sponsoring the meeting

All cancellations must be electronically mailed or postmarked by using the option "Modify registration".

Registration to this event is limited to a maximum of 100 total attendees. We are unable to accept additional registrants once the registration capacity has been met.

This conference is only for physicians and scientists who are currently practicing in the field of transplantation and cellular therapy and sponsoring companies. Please contact Gemma Puig (fundraising@ebmt.org) if you are interested in participating as a sponsor.

Refund of registration fees will be as follows:

In case of cancellation, up until one month prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges).
If the cancellation is notified between 15 and 30 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges).
Cancellations notified between 1 and 15 day registration fee will not be refunded.

Agenda

View the agenda.

View the Agenda

Housing

Madrid, the capital of Spain, is a prominent destination for scientific meetings, combining accessibility, a well-established scientific community, and a rich cultural heritage. The city hosts numerous research institutions and centers of innovation, making it an ideal setting for academic and professional collaboration. Its central location in Europe and excellent transportation infrastructure ensure ease of access for participants traveling from various international locations. The Novotel Madrid Centre serves as a suitable venue for congresses and events, offering modern facilities and adaptable meeting spaces. Situated within close proximity to key cultural and business areas, the venue provides a practical setting for hosting conferences and fostering professional engagement.

Novotel Madrid Center

Address: Calle de O'Donnell, 53, Salamanca, 28009 Madrid
Phone: +34 912 21 40 60

Sponsorship

There are various opportunities to support this meeting. For more information, please email fundraising@ebmt.org to indicate your interest.